Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Follicle Stimulating Hormone is important for fertility.

COVID-19 may harm male fertility and damage the reproductive system.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Prolactin may be important for skin growth and immune function.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.